Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) shares, rose in value, with the stock price up by 0.68% to the previous day’s close as strong demand from buyers drove the stock to $11.06.
Actively observing the price movement in the last trading, the stock closed the session at $10.98. Referring to stock’s 52-week performance, its high was $31.46, and the low was $9.56. On the whole, ZNTL has fluctuated by -27.19% over the past month.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 13.12M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ZNTL’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ZNTL currently trading nearly -20.13% and -21.20% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 32.35, while the 7-day volatility ratio is showing 6.58% which for the 30-day chart, stands at 7.02%. Furthermore, Zentalis Pharmaceuticals Inc (ZNTL)’s beta value is 1.82, and its average true range (ATR) is 0.94.
A comparison of Zentalis Pharmaceuticals Inc (ZNTL) with its peers suggests the former has fared considerably weaker in the market. ZNTL showed an intraday change of 0.68% in last session, and over the past year, it shrunk by -48.39%%.
Data on historical trading for Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) indicates that the trading volumes over the past 3 months, they’ve averaged 829.84K. According to company’s latest data on outstanding shares, there are 70.77 million shares outstanding.
Nearly 10.10% of Zentalis Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 110.03% of the company’s shares. The stock has fallen by -27.00% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ZNTL stock heading into the next quarter.
